Alaunos Therapeutics, Inc. Increase (Decrease) in Contract with Customer, Liability
Alaunos Therapeutics, Inc. (TCRT) reported Increase (Decrease) in Contract with Customer, Liability of -$146.00 thousand for the 12-month period ending 2018-12-31, per its 10-K filed 2021-03-01.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInContractWithCustomerLiability · last filed 2021-03-01
- Alaunos Therapeutics, Inc. increase (decrease) in contract with customer, liability for the quarter ending 2018-12-31 was $0.00.
- Alaunos Therapeutics, Inc. increase (decrease) in contract with customer, liability for the quarter ending 2018-09-30 was $0.00.
- Alaunos Therapeutics, Inc. increase (decrease) in contract with customer, liability for the quarter ending 2018-06-30 was $0.00.
- Alaunos Therapeutics, Inc. increase (decrease) in contract with customer, liability for the quarter ending 2018-03-31 was -$146.00K.
- Alaunos Therapeutics, Inc. increase (decrease) in contract with customer, liability for fiscal 2018 was -$146.00K.
- Alaunos Therapeutics, Inc. increase (decrease) in contract with customer, liability for fiscal 2017 was -$6.39M.
- Alaunos Therapeutics, Inc. increase (decrease) in contract with customer, liability for fiscal 2016 was -$6.86M.
| Period end | Increase (Decrease) in Contract with Customer, Liability 3 month | Increase (Decrease) in Contract with Customer, Liability 6 month | Increase (Decrease) in Contract with Customer, Liability 9 month | Increase (Decrease) in Contract with Customer, Liability 12 month |
|---|---|---|---|---|
| 2018-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-01 | $0.00 derived: sum of 2 quarters · filed 2021-03-01 | $0.00 derived: sum of 3 quarters · filed 2021-03-01 | -$146.00K 10-K · filed 2021-03-01 |
| 2018-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-07 | $0.00 derived: sum of 2 quarters · filed 2019-11-07 | -$146.00K 10-Q · filed 2019-11-07 | |
| 2018-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-08 | -$146.00K 10-Q · filed 2019-08-08 | ||
| 2018-03-31 | -$146.00K 10-Q · filed 2019-05-08 | |||
| 2017-12-31 | -$6.39M 10-K · filed 2020-03-02 | |||
| 2016-12-31 | -$6.86M 10-K · filed 2019-03-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| Sunshine Biopharma Inc. (SBFM) | $0.003B | ||
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Aptevo Therapeutics Inc. (APVO) | United States | $0.003B | |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |